Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
9.88
-0.65 (-6.22%)
At close: Oct 17, 2025, 3:59 PM
9.88
0.00%
After-hours: Oct 17, 2025, 04:10 PM EDT
Mersana Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 40.5M | 36.85M | 26.58M | 43K |
Cost of Revenue | 1.63M | 148.27M | 927K | 132.01M |
Gross Profit | 38.87M | -111.41M | 25.65M | -131.97M |
Operating Income | -73.34M | -170.96M | -204.69M | -169.71M |
Interest Income | 8.44M | 12.07M | 2.88M | 65K |
Pretax Income | -68.77M | -171.67M | -204.21M | -170.06M |
Net Income | -69.19M | -171.67M | -207.54M | -169.21M |
Selling & General & Admin | 40.81M | 59.54M | 56.96M | 36.89M |
Research & Development | 73.02M | 148.27M | 173.38M | 132.01M |
Other Expenses | n/a | n/a | -445K | -1.2M |
Operating Expenses | 113.83M | 36.85M | 230.35M | 168.9M |
Interest Expense | 3.87M | 4.07M | 3.33M | 1.27M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 113.83M | 207.81M | 230.35M | 168.9M |
Income Tax Expense | 418K | n/a | 3.33M | -855K |
Shares Outstanding (Basic) | 4.9M | 4.64M | 3.75M | 2.82M |
Shares Outstanding (Diluted) | 4.9M | 4.64M | 3.75M | 2.82M |
EPS (Basic) | -14.12 | -36.96 | -54.51 | -60.24 |
EPS (Diluted) | -14.12 | -36.96 | -54.51 | -60.24 |
EBITDA | -63.27M | -166.08M | -199.96M | -167.94M |
EBIT | -64.9M | -167.6M | -200.88M | -168.79M |
Depreciation & Amortization | 1.63M | 1.52M | 927K | 855K |
Source: Financial Modeling Prep. Financial Sources.